What is Competing in the Age of AI about?

Competing in the Age of AI is Marco Iansiti and Karim Lakhani's argument that artificial intelligence is not just another technology to be adopted, but a fundamental redesign of how firms operate — and that companies built from the start with AI at their core will eventually displace firms that try to bolt AI onto traditional operating models. Both authors are Harvard Business School professors who have spent years studying how technology reshapes industries, and the book draws on extensive case studies from companies including Amazon, Ant Financial, Alibaba, and Google.

The central concept is the "AI factory": a system that continuously collects data, processes it through algorithms, and deploys software at scale, replacing the judgment-intensive, human-bottlenecked decision trees that traditional businesses depend on. An AI-native firm like Amazon isn't just selling things online; it's running millions of small algorithmic decisions simultaneously — pricing, inventory, recommendation, logistics — with minimal human involvement in individual transactions. That operating model is fundamentally different from a traditional retailer, not just more efficient.

The authors argue that AI creates a new kind of competitive advantage: network effects operating through data. Each transaction generates data that improves the algorithm, which improves the service, which attracts more transactions. Unlike traditional businesses, where scale increases coordination costs, AI-native firms can scale without proportionally increasing human headcount. This makes the cost curves and competitive dynamics of AI-native firms structurally different from traditional ones.

The book's second half addresses strategy and leadership for incumbents trying to transform themselves. Iansiti and Lakhani are honest that this is hard: legacy systems, organizational structures, and cultures designed for human-intensive processes are resistant to redesign. They offer a framework for how incumbents can build AI capabilities incrementally, but the book is more confident about what AI-native firms can do than about how traditional firms can catch up. The gap between diagnosis and prescription is the book's main limitation.